You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Neurocutaneous Diseases
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Somatic Instability of the NF2 Gene in Schwannomatosis

David L. Kaufman, MD; Bianca S. Heinrich, MS; Christine Willett, BS; Arie Perry, MD; Frederick Finseth, MD; Raymond A. Sobel, MD; Mia MacCollin, MD

Arch Neurol. 2003;60:1317-1320.

Context  Schwannomatosis is a newly described form of neurofibromatosis of unclear pathogenesis.

Patient and Methods  We studied the NF2 locus on chromosome 22 in 7 tumor specimens resected from a 36-year-old man with schwannomatosis of the right ulnar nerve.

Results  Unrelated truncating NF2 gene mutations were detected in 4 tumor specimens. None of the NF2 mutations were present in the blood specimen. Loss of heterozygosity at the NF2 locus was seen in all tumors, and in every case the same allele was lost. Loss of distal chromosome 22 markers was variable. Fluorescence in situ hybridization results were consistent with monosomy 22 in 4 tumors and mitotic recombination or nondisjunction in 1.

Conclusions  Molecular analysis of tumor specimens distinguishes schwannomatosis from other forms of neurofibromatosis. Further work is needed to understand the natural history and molecular biology of this condition.


From the Departments of Plastic Surgery (Drs Kaufman and Finseth) and Pathology (Dr Sobel), Stanford University, Stanford, Calif; Department of Neurology, Massachusetts General Hospital, Charlestown (Mss Heinrich and Willett and Dr MacCollin); Division of Neuropathology, Washington University School of Medicine, St Louis, Mo (Dr Perry); and the Department of Plastic Surgery, El Camino Hospital, Mountain View, Calif (Dr Finseth).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis
Hadfield et al.
J. Med. Genet. 2008;45:332-339.
ABSTRACT | FULL TEXT  

The Immature Spine in Type-1 Neurofibromatosis
Crawford et al.
JBJS 2007;89:123-142.
FULL TEXT  

A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?
Murray et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:269-271.
ABSTRACT | FULL TEXT  

Diagnostic criteria for schwannomatosis
MacCollin et al.
Neurology 2005;64:1838-1845.
ABSTRACT | FULL TEXT  

Ophthalmological manifestations in segmental neurofibromatosis type 1
Ruggieri et al.
Br J Ophthalmol 2004;88:1429-1433.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.